Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Xenon Pharmaceuticals Inc (XENE)

NASDAQ
Currency in USD
Disclaimer
43.05
+0.05(+0.12%)
Closed
After Hours
43.050.00(0.00%)
Fair Value
Unlock Value
Day's Range
42.3843.54
52 wk Range
27.9950.99
Prev. Close
43
Open
42.88
Day's Range
42.38-43.54
52 wk Range
27.99-50.99
Volume
209,813
Average Volume (3m)
424,022
1-Year Change
24.21%
Shares Outstanding
75,432,482
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
57.44
Upside +33.43%

People Also Watch

124.42
ENSG
-0.96%
193.59
MSA
+0.20%
43.33
RYTM
+3.69%
59.03
BRBR
+0.39%
45.03
MRUS
+0.63%
How do you feel today about XENE?
Vote to see community's results!
or

Xenon Pharmaceuticals Company Profile

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company is focused on advancing its ion channel neurology pipeline. The Company's products within its novel proprietary pipeline include clinical-stage candidates XEN496 and XEN1101, which are focused on treating neurological disorders, with a particular focus on epilepsy. XEN1101 is a differentiated Kv7 potassium channel opener being developed for the treatment of epilepsy and major depressive disorder (MDD). The XEN496 is a Kv7 potassium channel opener, is a pediatric formulation of the active ingredient ezogabine being developed for the treatment of KCNQ2 developmental and epileptic encephalopathy, or KCNQ2-DEE. The Company has promising partnered products within its pipelines, such as NBI-921352 with Neurocrine Biosciences and PCRX301 with Pacira BioSciences.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.